High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)
AGENCY
HHS-NIH11
PROGRAM
Discretionary
AMOUNT
Up to $1.5M
CLOSES
Mar 5, 2027
Description
The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV among people who use drugs (PWUD). Applications submitted under this FOA are required to have a detailed research plan, preliminary data, and a clear description of the nexus with substance use. This FOA is open to both individual researchers and research teams and includes all areas of research from basic science to clinical and implementation research. All studies must focus on NIH HIV/AIDS Research Priorities: NOT-OD-20-018: UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding.
Eligibility
Private institutions of higher education; County governments; Special district governments; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Small businesses; Native American tribal governments (Federally recognized); For profit organizations other than small businesses; Public housing authorities/Indian housing authorities; Others (see text field entitled "Additional Information on Eligibility" for clarification); State governments; City or township governments; Public and State controlled institutions of higher education; Native American tribal organizations (other than Federally recognized tribal governments); Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Independent school districts
Contact
Additional details
- Funding instrument
- Grant
- Cost sharing required
- No
- Archived
- Apr 5, 2027
Opportunity number: RFA-DA-25-060
Search this number on Grants.gov for the official listing.